학술논문
Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
Document Type
Article
Author
Source
BMC Pharmacology & Toxicology; 12/20/2023, Vol. 24 Issue 1, p1-7, 7p
Subject
Language
ISSN
20506511
Abstract
Copyright of BMC Pharmacology & Toxicology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)